Sjölander Isabella, Hansen Frank, Elmanama Abdelraouf, Khayyat Rasha, Abu-Zant Alaeddin, Hussein Ayman, Taha Adham Abu, Hammerum Anette M, Ciofu Oana
Hudiksvall Hospital, Hudiksvall, Sweden; University of Copenhagen, Department of International Health, Immunology and Microbiology, Unit of Bacteriology, Costerton Biofilm Center, Copenhagen, Denmark.
Statens Serum Institut, Copenhagen, Denmark.
J Glob Antimicrob Resist. 2014 Jun;2(2):93-97. doi: 10.1016/j.jgar.2013.11.002. Epub 2013 Nov 23.
The aim of this study was to screen for carbapenem-resistant Gram-negative bacteria in Palestine and subsequently to identify and investigate the mechanisms of resistance. For a period of 6 weeks, all Gram-negative isolates were collected from six Palestinian hospital laboratories and were tested for susceptibility using 10μg meropenem disks. Isolates showing resistance to meropenem were further investigated. The presence of carbapenemases was assessed by PCR. In addition, antimicrobial susceptibility testing, an efflux pump inhibitor assay and pulsed-field gel electrophoresis (PFGE) were performed. Isolates producing carbapenemases were further investigated by multilocus sequence typing (MLST). In total, 248 Gram-negative isolates were collected from the six laboratories. Among the 248 tested isolates, 15 Acinetobacter baumannii and 6 Pseudomonas aeruginosa were resistant to meropenem. One A. baumannii from Gaza produced NDM-2 and belonged to ST103. Thirteen of the carbapenem-resistant A. baumannii isolates possessed the intrinsic upregulated bla gene and one isolate carried bla. All but one of the OXA-66-producing A. baumannii belonged to ST2; the remaining isolate belonged to ST183. One of the carbapenem-resistant P. aeruginosa was classified as VIM-4-producing and three were VIM-2-producing isolates. The three VIM-2-producing isolates belonged to three new sequences types (ST1562, ST1563 and ST1564). All of the carbapenemase-producing isolates were multiresistant non-fermenters. To the best of our knowledge, this is the first report on NDM-producing A. baumannii and VIM-producing P. aeruginosa from Palestine.
本研究的目的是在巴勒斯坦筛查耐碳青霉烯类革兰氏阴性菌,随后鉴定并研究其耐药机制。在为期6周的时间里,从巴勒斯坦的6家医院实验室收集了所有革兰氏阴性菌分离株,并用含10μg美罗培南的纸片进行药敏试验。对显示美罗培南耐药的分离株进一步研究。通过PCR评估碳青霉烯酶的存在。此外,还进行了药敏试验、外排泵抑制剂试验和脉冲场凝胶电泳(PFGE)。对产碳青霉烯酶的分离株通过多位点序列分型(MLST)进一步研究。总共从6个实验室收集了248株革兰氏阴性菌分离株。在248株受试分离株中,15株鲍曼不动杆菌和6株铜绿假单胞菌对美罗培南耐药。来自加沙的1株鲍曼不动杆菌产生NDM-2,属于ST103型。13株耐碳青霉烯类鲍曼不动杆菌分离株具有内在上调的bla基因,1株分离株携带bla基因。除1株外,产OXA-66的鲍曼不动杆菌均属于ST2型;其余1株属于ST183型。1株耐碳青霉烯类铜绿假单胞菌被分类为产VIM-4型,3株为产VIM-2型分离株。这3株产VIM-2型分离株属于3种新的序列类型(ST1562、ST1563和ST1564)。所有产碳青霉烯酶的分离株均为多重耐药非发酵菌。据我们所知,这是关于巴勒斯坦产NDM的鲍曼不动杆菌和产VIM的铜绿假单胞菌的首次报道。